AI Science Tracker
EN

Spatial Characterization of Tumor Perfusion Properties from 3D DCE-US Perfusion Maps are Early Predictors of Cancer Treatment Response

School of Medicine; Stanford University · 24 Apr 2020 · medicine

Discovery

Spatial Characterization of Tumor Perfusion Properties from 3D DCE-US Perfusion Maps are Early Predictors of Cancer Treatment Response

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Multivariate learned perfusion analysis identified response-associated tumor heterogeneity in mice and small clinical proof-of-principle data; exploratory response prediction only.

Technology: Multivariate learned perfusion analysis identified response-associated tumor heterogeneity in mice and small clinical proof-of-principle data; exploratory response prediction only.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Multivariate learned perfusion analysis identified response-associated tumor heterogeneity in mice and small clinical proof-of-principle data; exploratory response prediction only.
Limitation / still unknown
Multivariate learned perfusion analysis identified response-associated tumor heterogeneity in mice and small clinical proof-of-principle data; exploratory response prediction only. The source does not establish benefits beyond the reported evaluation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC7181711/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: other. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.